Home » Newsletters » BioWorld Science

BioWorld Science

July 18, 2002

View Archived Issues

Simvastatin inhibits thrombin-induced tissue factor expression via the Rho/Rho kinase pathway

British Biotech presents development highlights over the last year

Efficacy of T-3811ME against meningitis caused by penicillin-resistant pneumococci

Procyon and Chiron extend PSP94 technology option agreement

ETX-100 granted orphan drug designation in alpha1-antitrypsin deficiency

Guilford initiates phase II trial of Aquavan in surgical patients

Phase II begins for irofulven + irinotecan in advanced gastrointestinal solid tumors

Selective adenosine A3 receptor ligand reduces IOP in monkeys

Second genomics-derived drug from HGS/GSK collaboration enters clinical testing

Mexiletine homodimers with superior analgesic profile

In vitro and in vivo pharmacology of EGIS-8332, a new neuroprotective agent

Salicylic acid analogues with IL-4-antagonist activity identified at Sunesis

Aventis presents new antiarrhythmic potassium channel blockers

Mechanism of action of cognition enhancer CGP-36742/DVD-742

Glycine-site NMDA modulators and their use claimed in Gruenenthal patent

Novel p38alpha kinase inhibitors in early development at Scios

Vita-Invest claims dual 5-HT reuptake inhibitors/5-HT1A receptor modulators

Adenosine A1 antagonists and their use in hypertension and other disorders

Novel anti-HIV agents in the Roche pipeline

Japanese partners withdraw potential RA therapeutic from development

Zonagen regains Vasomax rights, submits data from mechanistic trial

Effects of BIBN-4096BS on hemodynamic changes induced by capsaicin

Xenical label in E.U. changed to include data on overweight or obese type 2 diabetes patients

Yamanouchi licenses North American development and marketing rights to Z-338

Elitek approved in U.S.

AIT-034 and piracetam possess different profiles of activity in animal models of cognition

Mild cognitive impairment: state-of-the-art seminar

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026